V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210031066 | 210012392 | 1.76 | 64.8 | Curative (C) | 2017-06-24 | 2017-10-04 | ALL UKALL2003 TRIAL | 02 | N | 210034672 | UKALL 2003 |
| 210031067 | 210012396 | 1.62 | 57.2 | Palliative (P) | 2018-04-14 | 2018-04-22 | ALL UKALL60+ TRIAL | N | N | 210034702 | UKALL60+ |
| 210031068 | 210012398 | null | 45.4 | Disease modification (D) | 2017-01-12 | 2017-04-20 | IDELALISIB + RITUXIMAB | N | N | 210034706 | IDELALISIB + RITUXIMAB |
| 210031069 | 210012401 | 1.71 | 77.9 | Curative (C) | 2015-08-22 | 2015-11-14 | ALL UKALL2003 TRIAL | N | N | 210034727 | UKALL 2003 |
| 210031070 | 210021868 | 1.6 | 23 | Curative (C) | 2014-10-05 | 2014-10-05 | ALL UKALL60+ TRIAL | 2 | N | 210034738 | UKALL60+ |
| 210031071 | 210012405 | 1.74 | 80 | Curative (C) | 2015-11-12 | 2016-01-15 | Triple / Double Intrathecal Therapy | 1 | N | 210034764 | TRIPLE INTRATHECAL |
| 210031072 | 210012408 | 1.76 | 55 | Disease modification (D) | 2013-07-09 | 2013-12-30 | CHLORAMBUCIL + RITUXIMAB | Y | N | 210034781 | CHLORAMBUCIL + RITUXIMAB |
| 210031073 | 210021874 | null | 91.4 | Curative (C) | 2017-09-12 | 2017-10-16 | CHLORAMBUCIL + OBINUTUZUMAB | 2 | N | 210034788 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210031074 | 210021875 | 1.59 | 82.2 | Curative (C) | 2013-09-25 | 2013-10-07 | ALL UKALL2003 TRIAL | 2 | N | 210034792 | UKALL 2003 |
| 210031075 | 210012411 | 0 | 0 | Disease modification (D) | 2015-11-23 | 2017-03-12 | IMATINIB | N | N | 210034795 | IMATINIB |
| 210031076 | 210031317 | 1.85 | 80 | Curative (C) | 2017-08-09 | 2017-12-04 | IMATINIB | N | N | 210034801 | IMATINIB |
| 210031077 | 210012416 | 1.69 | 45 | Curative (C) | 2015-05-15 | 2015-08-08 | ALL UKALL60+ TRIAL | 02 | N | 210034805 | UKALL60+ |
| 210031078 | 210021880 | 1.61 | 60.3 | null | 2014-04-04 | 2014-04-08 | IMATINIB | 1 | N | 210034842 | IMATINIB |
| 210031079 | 210012424 | 1.53 | 82.7 | null | 2015-04-16 | 2018-01-21 | Imatinib 600mg | 2 | null | 210034842 | IMATINIB |
| 210031080 | 210012428 | null | 61.2 | Curative (C) | 2017-04-03 | 2017-05-08 | R Chlorambucil | N | null | 210034854 | CHLORAMBUCIL + RITUXIMAB |
| 210031081 | 210012432 | 1.58 | 56 | Palliative (P) | 2016-09-25 | 2016-10-28 | IDELALISIB + RITUXIMAB | 2 | N | 210034981 | IDELALISIB + RITUXIMAB |
| 210031082 | 210012435 | null | 76 | Curative (C) | 2017-07-26 | 2017-07-26 | Triple / Double Intrathecal Therapy | null | null | 210034995 | TRIPLE INTRATHECAL |
| 210031083 | 210012442 | 1.77 | 91 | Palliative (P) | 2015-05-09 | 2015-08-02 | IMATINIB | N | N | 210035035 | IMATINIB |
| 210031084 | 210027745 | 1.64 | null | Curative (C) | 2017-08-27 | 2018-06-01 | ALL UKALL2003 TRIAL | 02 | null | 210035037 | UKALL 2003 |
| 210031085 | 210012443 | null | 83.3 | Curative (C) | 2014-03-28 | 2014-03-28 | METHOTREXATE | 2 | N | 210035047 | METHOTREXATE |
| 210031086 | 210021890 | 1.77 | 84.3 | Disease modification (D) | null | 2018-03-02 | METHOTREXATE | N | N | 210035080 | METHOTREXATE |
| 210031087 | 210012450 | 1.69 | 4.8 | Curative (C) | 2018-03-17 | 2018-03-17 | IDELALISIB + RITUXIMAB | N | N | 210035129 | IDELALISIB + RITUXIMAB |
| 210031088 | 210012452 | null | 29.3 | Palliative (P) | null | 2019-04-22 | IDELALISIB + RITUXIMAB | N | null | 210035136 | IDELALISIB + RITUXIMAB |
| 210031089 | 210012456 | 1.73 | 70 | Palliative (P) | 2016-10-28 | 2016-11-27 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | 210035165 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210031091 | 210027752 | 1.86 | 61 | null | 2016-08-05 | 2016-08-05 | METHOTREXATE | N | N | 210035205 | METHOTREXATE |
| 210031092 | 210027754 | 1.65 | 20.5 | Curative (C) | null | 2017-01-06 | IDELALISIB + RITUXIMAB | null | null | 210035264 | IDELALISIB + RITUXIMAB |
| 210031093 | 210012467 | 1.56 | 57.4 | Disease modification (D) | 2017-06-15 | 2017-07-09 | IDELALISIB + RITUXIMAB | null | Y | 210035272 | IDELALISIB + RITUXIMAB |
| 210031094 | 210012469 | 1.52 | 62.7 | Adjuvant (A) | 2014-12-08 | 2015-01-08 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | 210035278 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210031095 | 210012471 | 1.69 | 52.3 | Disease modification (D) | 2018-11-26 | 2018-12-10 | CHLORAMBUCIL + OBINUTUZUMAB | 1 | N | 210035280 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210031096 | 210012472 | 1.68 | 88 | Curative (C) | null | 2017-12-18 | ALL UKALL60+ TRIAL | null | null | 210035321 | UKALL60+ |
| 210031097 | 210012478 | 1.82 | 90 | Curative (C) | 2014-04-21 | 2014-06-17 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | 210035368 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210031098 | 210021910 | 1.73 | 75 | Adjuvant (A) | 2017-01-13 | 2017-11-19 | ALL UKALL2003 TRIAL | N | N | 210035412 | UKALL 2003 |
| 210031100 | 210021914 | 1.76 | 60 | Palliative (P) | 2015-10-13 | 2016-01-27 | Imatinib 400mg | N | null | 210035446 | IMATINIB |
| 210031101 | 210012490 | null | 102.3 | Curative (C) | 2015-11-22 | 2016-01-17 | CHLORAMBUCIL + OBINUTUZUMAB | 2 | Y | 210035449 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210031102 | 210012491 | null | 68.9 | Palliative (P) | 2017-11-23 | 2017-12-05 | CHLORAMBUCIL + RITUXIMAB | 02 | N | 210035459 | CHLORAMBUCIL + RITUXIMAB |
| 210031103 | 210027766 | 0 | 72.4 | Disease modification (D) | 2018-09-18 | 2018-10-30 | Triple / Double Intrathecal Therapy | 1 | N | 210035475 | TRIPLE INTRATHECAL |
| 210031104 | 210012499 | 1.77 | 73.5 | Adjuvant (A) | 2016-03-26 | 2016-03-28 | METHOTREXATE | N | N | 210035517 | METHOTREXATE |
| 210031105 | 210012500 | 1.62 | 0 | Palliative (P) | 2016-01-23 | 2018-08-25 | IDELALISIB + RITUXIMAB | null | N | 210035526 | IDELALISIB + RITUXIMAB |
| 210031106 | 210012507 | 1.5 | 90.15 | Palliative (P) | 2015-02-01 | 2015-06-20 | Methotrexate 10mg/m2 po 7day | N | null | 210035596 | METHOTREXATE |
| 210031107 | 210012509 | 1.78 | 9.6 | Disease modification (D) | null | 2015-01-02 | METHOTREXATE | N | N | 210035598 | METHOTREXATE |
| 210031108 | 210031342 | 1.66 | 66 | Curative (C) | 2015-08-21 | 2015-08-22 | IMATINIB | 02 | N | 210035630 | IMATINIB |
| 210031109 | 210021931 | 1.64 | 65 | Curative (C) | 2017-10-13 | 2018-08-25 | CHLORAMBUCIL + OBINUTUZUMAB | null | null | 210035643 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210031110 | 210012516 | null | 83.3 | null | 2014-10-15 | 2015-05-16 | Imatinib 600mg | N | null | 210035656 | IMATINIB |
| 210031111 | 210031343 | 1.76 | 89.5 | Disease modification (D) | 2017-06-14 | 2017-06-15 | Triple Intrathecal | 02 | null | 210035668 | TRIPLE INTRATHECAL |
| 210031112 | 210012520 | 1.73 | 27 | Palliative (P) | 2012-03-29 | 2013-09-06 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | 210035673 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210031113 | 210012521 | 1.57 | 59.4 | Disease modification (D) | 2017-12-27 | 2018-07-22 | IDELALISIB + RITUXIMAB | N | N | 210035683 | IDELALISIB + RITUXIMAB |
| 210031114 | 210021937 | 1.6 | 70.2 | null | 2017-06-01 | 2017-08-20 | ALL UKALL60+ TRIAL | N | N | 210035695 | UKALL60+ |
| 210031115 | 210035098 | 1.84 | 88 | null | 2019-01-07 | 2019-04-24 | METHOTREXATE | 1 | null | 210035764 | METHOTREXATE |
| 210031116 | 210012537 | 0 | 23 | Disease modification (D) | 2018-06-26 | 2018-08-12 | IDELALISIB + RITUXIMAB | N | N | 210035795 | IDELALISIB + RITUXIMAB |
| 210031117 | 210012539 | 1.7 | 79 | Curative (C) | 2019-04-02 | 2019-05-10 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | 210035805 | CHLORAMBUCIL + OBINUTUZUMAB |